BPG is committed to discovery and dissemination of knowledge
Articles in Press
9/10/2026 10:08:05 AM | Browse: 1 | Download: 0
Publication Name World Journal of Hepatology
Manuscript ID 125505
DOI 10.4254/wjh.125505
Country Croatia
Category Gastroenterology & Hepatology
Manuscript Type Prospective Study
Article Title Changes in lipid biomarkers, liver stiffness and steatosis following sodium-glucose cotransporter two inhibitor therapy in type two diabetes
Manuscript Source Unsolicited Manuscript
All Author List Farah Khaznadar, Kristina Bojanic, Omar Khaznadar, Ana Jurić, Marija Hefer, Kristina Kralik, Ana Petrović, Ana Hrženjak, Ana Lončar, Justinija Steiner, Martina Smolić and Robert Smolić
Funding Agency and Grant Number
Funding Agency Grant Number
European Union-Next Generation EU through programme funding of the University of Osijek (UNIOS)-Institutional Project 581-UNIOS-46
Corresponding Author Martina Smolić, Full Professor, Research Dean, Department of Translational Medicine, Faculty of Dental Medicine and Health Osijek, Josip Juraj Strossmayer University of Osijek, Crkvena 21, Osijek 31000, Croatia. msmolic@fdmz.hr
Key Words Metabolic dysfunction-associated steatotic liver disease; Type 2 diabetes mellitus; Sodium-glucose cotransporter 2 inhibitors; Two-dimensional shear wave elastography; Ultrasound-guided attenuation parameter; Sterol regulatory element-binding protein 1c; Peroxisome proliferator-activated receptor gamma; Peroxisome proliferator-activated receptor alpha; Microsomal triglyceride transfer protein
Core Tip Metabolic dysfunction-associated steatotic liver disease lacks effective pharmacologic therapies and robust biomarkers for monitoring treatment response. In this prospective observational study, sodium-glucose cotransporter 2 inhibitors therapy was associated with modulation of selected circulating lipogenesis biomarkers and a modest reduction in liver stiffness of uncertain clinical relevance, whereas steatosis measures remained largely unchanged over 6 months.
Citation Khaznadar F, Bojanic K, Khaznadar O, Jurić A, Hefer M, Kralik K, Petrović A, Hrženjak A, Lončar A, Steiner J, Smolić M, Smolić R. Changes in lipid biomarkers, liver stiffness and steatosis following sodium-glucose cotransporter two inhibitor therapy in type two diabetes. World J Hepatol 2026; In press
PDF 125505-in-press.pdf
Received
2026-07-09 06:12
Peer-Review Started
2026-07-09 06:13
First Decision by Editorial Office Director
Return for Revision
2026-07-23 07:56
Revised
2026-08-03 18:31
Publication Fee Transferred
2026-08-21 09:10
Second Decision by Editor
2026-09-10 02:43
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-09-10 10:08
Articles in Press
2026-09-10 10:08
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5182 (online)
Open Access Open-Access: This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com